Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Deeks

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Blood|February 29, 2012
Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persistsPaul D Baum, Jennifer J Young, Diane Schmidt, et al.
AIDS (London, England)|April 16, 2024
Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small moleculesGayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, et al.
AIDS (London, England)|May 24, 2013
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAlison J Rodger, Rebecca Lodwick, Mauro Schechter, et al.
Journal of the American Heart Association|May 1, 2016
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox"Payal Kohli, Peter Ganz, Yifei Ma, et al.
Journal of Virus Eradication|February 16, 2016
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness AnalysisKenneth A Freedberg, Cristina Possas, Steven Deeks, et al.
AIDS (London, England)|October 22, 2019
Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infectionDenise C Hsu, Yi Fei Ma, Amrit Narwan, et al.
AIDS (London, England)|September 16, 2015
Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individualsFelicia C Chow, W John Boscardin, Claire Mills, et al.
AIDS (London, England)|May 14, 2016
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapyDenise C Hsu, Yi Fei Ma, Sophia Hur, et al.
Journal of Virology|November 30, 2022
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed IndividualsHolly Anne Martin, Gayatri Nikhila Kadiyala, Sushama Telwatte, et al.
Journal of the American Heart Association|November 2, 2021
Effect of HIV-1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial DysfunctionAnjali B Thakkar, Yifei Ma, Mark Dela Cruz, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Blood|February 29, 2012
Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persistsPaul D Baum, Jennifer J Young, Diane Schmidt, et al.
AIDS (London, England)|April 16, 2024
Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small moleculesGayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, et al.
AIDS (London, England)|May 24, 2013
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAlison J Rodger, Rebecca Lodwick, Mauro Schechter, et al.
Journal of the American Heart Association|May 1, 2016
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox"Payal Kohli, Peter Ganz, Yifei Ma, et al.
Journal of Virus Eradication|February 16, 2016
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness AnalysisKenneth A Freedberg, Cristina Possas, Steven Deeks, et al.
AIDS (London, England)|October 22, 2019
Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infectionDenise C Hsu, Yi Fei Ma, Amrit Narwan, et al.
AIDS (London, England)|September 16, 2015
Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individualsFelicia C Chow, W John Boscardin, Claire Mills, et al.
AIDS (London, England)|May 14, 2016
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapyDenise C Hsu, Yi Fei Ma, Sophia Hur, et al.
Journal of Virology|November 30, 2022
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed IndividualsHolly Anne Martin, Gayatri Nikhila Kadiyala, Sushama Telwatte, et al.
Journal of the American Heart Association|November 2, 2021
Effect of HIV-1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial DysfunctionAnjali B Thakkar, Yifei Ma, Mark Dela Cruz, et al.
Pageof 5